GoodRx
GDRX
3.25
-0.02
-0.61%
GoodRx
US · GDRX
#3178 by market cap
Listed 2020
3.25
-0.02
-0.61%
Live - 5344 symbols - heartbeat 279s ago
· 2026-10-08 08:13
Pre-market
3.20
-1.45%
After-hours
3.25
0.00%
- Market cap
- 1.11B
- P/E (TTM)i
- 54.17
- P/Bi
- 1.71
- EPSi
- 0.09
- Div yieldi
- 0.00%
- 52W posi
- 58%
Reader sentiment
Are you bullish or bearish on GDRX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.55, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.57% YoY
Margins
- Gross margin
- 92.77%
- Operating margin
- 10.98%
- Net margin
- 3.82%
Key ratios & quality
- Enterprise valuei
- 1.34B
- Altman Z-Scorei
- 0.55
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 249.52M | 388.22M | 550.70M | 745.42M | 766.55M | 750.27M | 792.32M | 796.85M |
| Gross profit | 243.49M | 374.21M | 521.11M | 698.71M | 701.48M | 683.34M | 744.11M | 739.26M |
| Selling & admin expenses | 112.54M | 191.66M | 716.59M | 524.90M | 502.42M | 466.84M | 484.98M | 445.52M |
| Research & development | 43.89M | 29.30M | 61.82M | 125.86M | 143.14M | 135.84M | 123.75M | 121.03M |
| Operating profit | 77.25M | 139.68M | -275.72M | 13.41M | 1.74M | -27.01M | 65.85M | 87.49M |
| Pretax profit | 52.35M | 82.98M | -303.45M | -10.18M | -23.23M | -55.57M | 31.46M | 56.54M |
| Tax | 8.56M | 16.93M | -9.83M | 15.08M | 9.60M | -46.70M | 15.07M | 26.10M |
| Net profit | 43.79M | 66.05M | -293.62M | -25.25M | -32.83M | -8.87M | 16.39M | 30.44M |
| Basic EPS | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.04 | 0.12 | -1.07 | -0.06 | -0.08 | -0.02 | 0.04 | 0.09 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 202.97M | 203.07M | 196.03M | 194.79M | 194.01M | 200.41M |
| Gross profit | 189.61M | 189.72M | 182.61M | 177.32M | 173.85M | 179.41M |
| Selling & admin expenses | 114.17M | 113.25M | 115.55M | 102.55M | 107.87M | 106.80M |
| Research & development | 31.14M | 29.93M | 31.01M | 28.94M | 30.18M | 26.71M |
| Operating profit | 23.38M | 26.81M | 14.62M | 22.68M | 14.01M | 23.63M |
| Pretax profit | 16.67M | 19.58M | 6.10M | 14.19M | 5.64M | 15.47M |
| Tax | 5.62M | 6.73M | 4.98M | 8.77M | 4.47M | 6.93M |
| Net profit | 11.05M | 12.84M | 1.12M | 5.43M | 1.17M | 8.54M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.03 | 0.04 | 0.00 | 0.02 | 0.00 | 0.02 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 73.07M | 86.58M | 1.09B | 1.09B | 919.69M | 872.79M | 659.26M | 643.10M |
| Cash & ST investments | 34.60M | 26.05M | 968.69M | 941.11M | 757.17M | 672.30M | 448.35M | 261.82M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 314.79M | 386.80M | 1.47B | 1.61B | 1.60B | 1.59B | 1.39B | 1.40B |
| Total current liabilities | 16.62M | 33.37M | 59.55M | 81.11M | 76.32M | 122.56M | 123.90M | 246.00M |
| Short-term debt | 5.43M | 9.97M | 11.57M | 12.88M | 11.10M | 14.96M | 10.64M | 9.75M |
| Long-term debt | 716.81M | 663.89M | 659.89M | 655.86M | 651.80M | 647.70M | 486.71M | 483.26M |
| Total liabilities | 1,477,218,000.00 | 1,474,378,000.00 | 758,755,000.00 | 775,945,000.00 | 789,804,000.00 | 826,842,000.00 | 663,409,000.00 | 787,796,000.00 |
| Total equity | -1.16B | -1.09B | 711.36M | 831.68M | 814.83M | 761.96M | 724.66M | 616.26M |
| Retained earnings | -1.16B | -1.10B | -1.39B | -1.42B | -1.45B | -1.46B | -1.44B | -1.41B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 540.21M | 550.61M | 565.52M | 643.10M | 1.27B | 1.60B |
| Cash & ST investments | 300.98M | 281.32M | 273.53M | 261.82M | 235.71M | 296.11M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 1.30B | 1.32B | 1.33B | 1.40B | 2.02B | 2.34B |
| Total current liabilities | 103.38M | 130.91M | 181.86M | 246.00M | 859.20M | 1.16B |
| Short-term debt | 10.56M | 9.82M | 9.76M | 9.75M | 9.98M | 10.36M |
| Long-term debt | 485.84M | 484.97M | 484.11M | 483.26M | 482.42M | 481.59M |
| Total liabilities | 640,924,000.00 | 675,675,000.00 | 724,795,000.00 | 787,796,000.00 | 1,399,265,000.00 | 1,695,327,000.00 |
| Total equity | 654.35M | 643.03M | 600.71M | 616.26M | 621.99M | 647.60M |
| Retained earnings | -1.43B | -1.42B | -1.42B | -1.41B | -1.41B | -1.40B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 45.25M | 83.29M | 131.34M | 178.78M | 146.78M | 138.29M | 183.89M | 167.90M |
| Depreciation & amortization | 9.81M | 13.57M | 18.43M | 34.54M | 54.18M | 107.67M | 69.54M | 85.22M |
| Free cash flow | 41.80M | 77.54M | 95.52M | 144.32M | 91.57M | 82.53M | 113.55M | 93.88M |
| Dividends paid | -1.35B | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 1.62M | 991.79M | 0 | -101.72M | -103.97M | -158.85M | -216.37M |
| Ending cash balance | 34.60M | 26.05M | 971.59M | 941.11M | 757.17M | 672.30M | 448.35M | 261.82M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 9.41M | 49.58M | 76.02M | 32.89M | 11.84M | 80.83M |
| Depreciation & amortization | 20.91M | 19.73M | 21.43M | 23.15M | 21.79M | 22.27M |
| Free cash flow | -12.46M | 31.27M | 58.02M | 17.06M | -9.81M | 66.42M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -99.90M | -45.99M | -61.05M | -9.43M | -12.57M | -1.95M |
| Ending cash balance | 300.98M | 281.32M | 273.53M | 261.82M | 235.71M | 296.11M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -3.27 | -3.99 | -1.12 | 2.21 | 4.54 |
| ROA %i | 4.38 | 18.83 | -31.62 | -1.64 | -2.04 | -0.56 | 1.10 | 2.18 |
| ROIC %i | -- | -- | -- | -0.54 | -0.85 | 0.70 | 2.90 | 4.57 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -0.33 |
| EBIT margin %i | 29.87 | 34.14 | -50.03 | 1.81 | 1.44 | 0.15 | 10.65 | 12.44 |
| FCF / sales %i | 16.75 | 19.97 | 17.34 | 19.36 | 11.95 | 11.00 | 14.33 | 11.78 |
| Current ratioi | 4.40 | 2.59 | 18.24 | 13.42 | 12.05 | 7.12 | 5.32 | 2.61 |
| Quick ratioi | 4.19 | 2.44 | 17.90 | 13.16 | 11.52 | 6.79 | 4.92 | 2.10 |
| Debt / assetsi | 229.43 | 183.81 | 47.95 | 43.69 | 44.68 | 44.76 | 39.15 | 38.66 |
| LT debt / equityi | -- | -- | 97.47 | 82.90 | 86.64 | 91.36 | 73.52 | 86.50 |
| Interest coveragei | 3.36 | 2.67 | -9.87 | 0.57 | 0.32 | 0.02 | 1.59 | 2.33 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 44.02 | 25.45 | 10.86 | 2.05 | 1.30 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | 51.15 | 5.70 | -4.76 | -7.68 | 0.84 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 4.43 | 5.27 | 4.90 | 4.54 | 3.22 | 2.52 |
| ROA %i | 2.07 | 2.48 | 2.37 | 2.18 | 1.24 | 0.89 |
| ROIC %i | 4.07 | 4.10 | 4.64 | 4.57 | 3.44 | 3.09 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.13 | 12.61 | 12.15 | 12.44 | 11.07 | 10.47 |
| FCF / sales %i | 9.92 | 14.74 | 13.11 | 11.78 | 12.25 | 16.77 |
| Current ratioi | 5.23 | 4.21 | 3.11 | 2.61 | 1.47 | 1.38 |
| Quick ratioi | 4.58 | 3.69 | 2.70 | 2.10 | 0.55 | 0.41 |
| Debt / assetsi | 41.78 | 41.52 | 41.13 | 38.66 | 26.78 | 23.00 |
| LT debt / equityi | 81.09 | 83.62 | 89.12 | 86.50 | 85.43 | 81.62 |
| Interest coveragei | 1.98 | 2.24 | 2.23 | 2.33 | 2.09 | 2.01 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 08:13:19 · For reference only, not investment advice and not tailored to your situation.